The global cell analysis market size surpassed USD 30.01 billion in 2023 and is estimated to increase from USD 32.95 billion in 2024 to approximately USD 84.01 billion by 2034. It is projected to grow at a CAGR of 9.81% from 2024 to 2034.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Cell Analysis Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Cell Analysis Market, by Product & Service, 2024-2034
8.1.1. Reagents & Consumables
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Instruments
8.1.2.1. Market Revenue and Forecast (2021-2034)
8.1.3. Accessories
8.1.3.1. Market Revenue and Forecast (2021-2034)
8.1.4. Software
8.1.4.1. Market Revenue and Forecast (2021-2034)
8.1.5. Service
8.1.5.1. Market Revenue and Forecast (2021-2034)
9.1. Cell Analysis Market, by Technique, 2024-2034
9.1.1. Flow Cytometry
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Cell Microarrays
9.1.2.1. Market Revenue and Forecast (2021-2034)
9.1.3. Microscopy
9.1.3.1. Market Revenue and Forecast (2021-2034)
9.1.4. PCR
9.1.4.1. Market Revenue and Forecast (2021-2034)
9.1.5. Spectrophotometry
9.1.5.1. Market Revenue and Forecast (2021-2034)
9.1.6. High Content-Screening
9.1.6.1. Market Revenue and Forecast (2021-2034)
9.1.7. Other Techniques
9.1.7.1. Market Revenue and Forecast (2021-2034)
10.1. Cell Analysis Market, by Process, 2024-2034
10.1.1. Cell Identification
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Cell Proliferation
10.1.2.1. Market Revenue and Forecast (2021-2034)
10.1.3. Cell Signaling Pathways
10.1.3.1. Market Revenue and Forecast (2021-2034)
10.1.4. Cell Interaction
10.1.4.1. Market Revenue and Forecast (2021-2034)
10.1.5. Cell Counting
10.1.5.1. Market Revenue and Forecast (2021-2034)
10.1.6. Cell Viability
10.1.6.1. Market Revenue and Forecast (2021-2034)
10.1.7. Cell Structure Study
10.1.7.1. Market Revenue and Forecast (2021-2034)
10.1.8. Single-cell Analysis
10.1.8.1. Market Revenue and Forecast (2021-2034)
10.1.9. Others
10.1.9.1. Market Revenue and Forecast (2021-2034)
11.1. Cell Analysis Market, by End-Use, 2024-2034
11.1.1. Pharmaceutical and Biotechnology Companies
11.1.1.1. Market Revenue and Forecast (2021-2034)
11.1.2. Academic and Research Institutes
11.1.2.1. Market Revenue and Forecast (2021-2034)
11.1.3. Hospitals and Clinical Testing Laboratories
11.1.3.1. Market Revenue and Forecast (2021-2034)
11.1.4. Other
11.1.4.1. Market Revenue and Forecast (2021-2034)
12.1. North America
12.1.1. Market Revenue and Forecast, by Product & Service (2021-2034)
12.1.2. Market Revenue and Forecast, by Technique (2021-2034)
12.1.3. Market Revenue and Forecast, by Process (2021-2034)
12.1.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Product & Service (2021-2034)
12.1.5.2. Market Revenue and Forecast, by Technique (2021-2034)
12.1.5.3. Market Revenue and Forecast, by Process (2021-2034)
12.1.5.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Product & Service (2021-2034)
12.1.6.2. Market Revenue and Forecast, by Technique (2021-2034)
12.1.6.3. Market Revenue and Forecast, by Process (2021-2034)
12.1.6.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Product & Service (2021-2034)
12.2.2. Market Revenue and Forecast, by Technique (2021-2034)
12.2.3. Market Revenue and Forecast, by Process (2021-2034)
12.2.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Product & Service (2021-2034)
12.2.5.2. Market Revenue and Forecast, by Technique (2021-2034)
12.2.5.3. Market Revenue and Forecast, by Process (2021-2034)
12.2.5.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Product & Service (2021-2034)
12.2.6.2. Market Revenue and Forecast, by Technique (2021-2034)
12.2.6.3. Market Revenue and Forecast, by Process (2021-2034)
12.2.6.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Product & Service (2021-2034)
12.2.7.2. Market Revenue and Forecast, by Technique (2021-2034)
12.2.7.3. Market Revenue and Forecast, by Process (2021-2034)
12.2.7.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Product & Service (2021-2034)
12.2.8.2. Market Revenue and Forecast, by Technique (2021-2034)
12.2.8.3. Market Revenue and Forecast, by Process (2021-2034)
12.2.8.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Product & Service (2021-2034)
12.3.2. Market Revenue and Forecast, by Technique (2021-2034)
12.3.3. Market Revenue and Forecast, by Process (2021-2034)
12.3.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Product & Service (2021-2034)
12.3.5.2. Market Revenue and Forecast, by Technique (2021-2034)
12.3.5.3. Market Revenue and Forecast, by Process (2021-2034)
12.3.5.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Product & Service (2021-2034)
12.3.6.2. Market Revenue and Forecast, by Technique (2021-2034)
12.3.6.3. Market Revenue and Forecast, by Process (2021-2034)
12.3.6.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Product & Service (2021-2034)
12.3.7.2. Market Revenue and Forecast, by Technique (2021-2034)
12.3.7.3. Market Revenue and Forecast, by Process (2021-2034)
12.3.7.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Product & Service (2021-2034)
12.3.8.2. Market Revenue and Forecast, by Technique (2021-2034)
12.3.8.3. Market Revenue and Forecast, by Process (2021-2034)
12.3.8.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Product & Service (2021-2034)
12.4.2. Market Revenue and Forecast, by Technique (2021-2034)
12.4.3. Market Revenue and Forecast, by Process (2021-2034)
12.4.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Product & Service (2021-2034)
12.4.5.2. Market Revenue and Forecast, by Technique (2021-2034)
12.4.5.3. Market Revenue and Forecast, by Process (2021-2034)
12.4.5.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Product & Service (2021-2034)
12.4.6.2. Market Revenue and Forecast, by Technique (2021-2034)
12.4.6.3. Market Revenue and Forecast, by Process (2021-2034)
12.4.6.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Product & Service (2021-2034)
12.4.7.2. Market Revenue and Forecast, by Technique (2021-2034)
12.4.7.3. Market Revenue and Forecast, by Process (2021-2034)
12.4.7.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Product & Service (2021-2034)
12.4.8.2. Market Revenue and Forecast, by Technique (2021-2034)
12.4.8.3. Market Revenue and Forecast, by Process (2021-2034)
12.4.8.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Product & Service (2021-2034)
12.5.2. Market Revenue and Forecast, by Technique (2021-2034)
12.5.3. Market Revenue and Forecast, by Process (2021-2034)
12.5.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Product & Service (2021-2034)
12.5.5.2. Market Revenue and Forecast, by Technique (2021-2034)
12.5.5.3. Market Revenue and Forecast, by Process (2021-2034)
12.5.5.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Product & Service (2021-2034)
12.5.6.2. Market Revenue and Forecast, by Technique (2021-2034)
12.5.6.3. Market Revenue and Forecast, by Process (2021-2034)
12.5.6.4. Market Revenue and Forecast, by End-Use (2021-2034)
13.1. Thermo Fisher Scientific, Inc.
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Danaher
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Merck KGaA
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Agilent Technologies, Inc.
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. BD
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Bio-Rad Laboratories, Inc.
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Miltenyl Biotech
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Revvity
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. New England Biolabs
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Avantor, Inc.
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample